Mathias Heikenwälder

German Cancer Research Center — Germany

Medicine · Health Sciences

106h-index45.3kcitations637works5.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(108), Hepatitis B Virus Studies(56), Immune Cell Function and Interaction(48), Liver physiology and pathology(41), Immunotherapy and Immune Responses(40)

Publications634 total

Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma
Nature Medicine·2026Open Access
ER Stress Sensor Atf6α is Decisive for T cell Tumor Immunosurveillance in MASH-HCC
Zeitschrift für Gastroenterologie·2026
Dual role of antioxidant Astaxanthin mediated NRF2 activation in MASH and MASH-induced HCC
Zeitschrift für Gastroenterologie·2026
From Cold to Inflamed: Targeting CMTM6 to Sensitize Liver Tumors to CD8+ Immunity
Zeitschrift für Gastroenterologie·2026
Cholangiocarcinoma 2026: status quo, unmet needs and priorities
Nature Reviews Gastroenterology & Hepatology·2025· 4 citedOpen Access
Single cell mapping identifies a distinct platelet-phenotype in psoriatic type III inflammation
Nature Communications·2025· 1 citedOpen Access
Lymphotoxin alpha eradicates acute myeloid leukemia and simultaneously promotes healthy hematopoiesis in mice
Science Translational Medicine·2025
Author Correction: CD8+ T cells induce cachexia during chronic viral infection
Nature Immunology·2025Open Access
A global survey of taxa-metabolic associations across mouse microbiome communities
Cell Host & Microbe·2025Open Access
Targeting peroxiredoxin 2 prevents hepatocarcinogenesis in metabolic liver disease
Free Radical Biology and Medicine·2025
Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab
Journal for ImmunoTherapy of Cancer·2025Open Access
A Lymphotoxin-Driven Pathway to Hepatocellular Carcinoma
Cancer Cell·2025
Shooting for the stars: caspase-8–meteorin in MASH and fibrosis
Nature Metabolism·2025
Targeting peroxiredoxin 2 prevents hepatocarcinogenesis in metabolic liver disease models
Journal of Clinical Investigation·2025· 1 citedOpen Access
Bifidobacteria-derived exopolysaccharide promotes anti-tumor immunity
Cell Reports·2025· 4 citedOpen Access
ATF6 activation alters colonic lipid metabolism causing tumour-associated microbial adaptation
Nature Metabolism·2025· 3 citedOpen Access
04PNovel mouse model for inclusion body myositis: transgenic upregulation of lymphotoxin together with impaired autophagy induces inflammation and protein accumulation in skeletal muscle
Neuromuscular Disorders·2025Open Access
Mutual reinforcement of lymphotoxin-driven myositis and impaired autophagy in murine muscle
Brain·2025Open Access
Claudin-1 is a mediator and therapeutic target in primary sclerosing cholangitis
Journal of Hepatology·2025· 2 citedOpen Access
Ultra-high-scale cytometry-based cellular interaction mapping
Nature Methods·2025· 4 citedOpen Access
page 1 of 32Next →

Frequent Co-authors

Achim Weber(10), Lars Zender(8), Adriano Aguzzi(8), Florian Reisinger(6), Frank Tacke(5), Tom Luedde(5), Marco Prinz(5), Monika Wolf(5), Mihael Vucur(4), Jesús Gil(4), Dominik Pfister(4), Jeffrey L. Browning(4), Suchira Gallage(4), Sabrina Klotz(4), Danijela Heide(4), Josep M. Llovet(3), Eli Pikarsky(3), Thomas Longerich(3), Katrin Kierdorf(3), Tobias Goldmann(3)